
Michael Chao-Hwa Wu MD
Anterior Segment Related, Cataract Related, Cornea & External Disease, Refractive Surgery
Cornea Specialist at Group Health Ophthalmology
Join to view full profile
11511 NE 10th StBellevue, WA 98004
Phone+1 425-502-3000
Fax+1 425-502-3356
Dr. Wu is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of North Carolina HospitalsInternship, Internal Medicine, 1998 - 1999
University of Texas Southwestern Medical SchoolClass of 1998, M.D.
University of Southern California/LAC+USC Medical CenterFellowship, Cornea, External Diseases, and Refractive Surgery
MedStar Health Georgetown UniversityResidency, Ophthalmology
Certifications & Licensure
CA State Medical License 2003 - 2027
WA State Medical License 2004 - 2027
NC State Medical License 1998 - 2000
American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Best Doctors in America, 2013-2014 Best Doctors, 2013
- U.S. News and World Report Top Doctors 2012: Ophthalmology U.S. News and World Report, 2012
- Castle Connolly Top Doctors Castle Connolly Medical Ltd., 2012
Publications & Presentations
PubMed
- 2 citationsCellular Neighborhoods Govern Antitumor T-cell Infiltration Following Anti-CTLA-4 in Melanoma with Primary Resistance to Anti-PD-1.Katie M Campbell, Daniel G Chen, Zaid E Bustami, Nataly Naser Al Deen, Egmidio Medina
Cancer Discovery. 2026-09-01 - 5 citationsNeoadjuvant PD-1 blockade in surgically resectable desmoplastic melanoma: cohort A of the phase 2 SWOG S1512 trial.Kari L Kendra, Shay L Bellasea, Zeynep Eroglu, Siwen Hu-Lieskovan, Katie M Campbell
Nature Cancer. 2026-02-01 - 8 citationsAnti-PD-1 therapy in unresectable desmoplastic melanoma: the phase 2 SWOG S1512 trial.Kari L Kendra, Shay L Bellasea, Zeynep Eroglu, Siwen Hu-Lieskovan, Katie M Campbell
Nature Medicine. 2025-11-01
Professional Memberships
- Fellow
- The Cornea SocietyMember
- Member
- Max Fine Cornea SocietyMember
- Association for Research in Vision and OphthalmologyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: